Search Results for 'Dtg-Nrtis'

Dtg-Nrtis published presentations and documents on DocSlides.

DTG vs LPV/r (DAWNING): Efficacy
DTG vs LPV/r (DAWNING): Efficacy
by winnie
by Baseline NRTI Resistance . and Second-Line NRTI...
Superior Efficacy of Dolutegravir (DTG) Plus
Superior Efficacy of Dolutegravir (DTG) Plus
by celsa-spraggs
2 Nucleoside Reverse Transcriptase Inhibitors (NR...
DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs
DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs
by maximus
DRIVE FORWARD. Doravirine. + 2 NRTIs vs. Darunavi...
Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs
Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs
by roxanne
FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...
LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in
LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in
by lucy
Virologically. Suppressed. OLE Trial. LPV-RTV + ....
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
CROI 2019:  ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
Updated WHO Treatment Guidelines  &
Updated WHO Treatment Guidelines &
by mitsue-stanley
Data . from other . cohorts and . regions to guid...
DTG/3TC 1st line (GEMINI)
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
Switch to DTG/3TC TANGO Design
Switch to DTG/3TC TANGO Design
by lam
Endpoints. Primary: proportion of patients with HI...
Switch to DTG/ABC/3TC
Switch to DTG/ABC/3TC
by karlyn-bohler
STRIIVING . Study. Design. Endpoints. Primary: pr...
DTG-Based Regimens Are Active in INI-Naive Patients With a
DTG-Based Regimens Are Active in INI-Naive Patients With a
by trish-goza
Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...
Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine
Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine
by kylie
STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...
A nti- R etroviral  T herapy Basics
A nti- R etroviral T herapy Basics
by caroline
E Duke. https://www.hiv.uw.edu/page/treatment/drug...
Optimizing HIV treatment
Optimizing HIV treatment
by anderson
Professor Francois Venter. Ezintsha, University of...
Lopinavir -RTV  +  NVP  +
Lopinavir -RTV + NVP +
by thomas
2 NRTIs in Treatment-Experienced. M97-765 Trial. L...
ART Resistance and  Second Line Regimens
ART Resistance and Second Line Regimens
by calandra-battersby
Learning Objectives. Understand when to switch to...
Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How
Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How
by taylor
Supported by an educational grant from Gilead Scie...
ART in Women and  Contraception: InSTIs
ART in Women and Contraception: InSTIs
by olivia-moreira
ART in Women and Contraception: InSTIs , Comorbi...
JM Llibre , 1  C-C Hung,
JM Llibre , 1 C-C Hung,
by mohammad106
2. C Brinson,. 3. F Castelli,. 4. P-M Girard,. ...
Custom Hoodies - No Minimum, Custom DTG Atlanta at 3V Printing Store
Custom Hoodies - No Minimum, Custom DTG Atlanta at 3V Printing Store
by 3vprintingstore
In the bustling city of Atlanta, fashion-forward i...
Updates on Individual and Universal HIV Treatment Strategies
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
Antiretrovirals for prevention in women of childbearing age:
Antiretrovirals for prevention in women of childbearing age:
by tremblay
issues to consider. Landon Myer. We all have “is...
Optimization of Antiretroviral Therapy
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Basic HIV Course for Health Professionals
Basic HIV Course for Health Professionals
by megan
Session 12: Contraceptives and HIV. Learning Objec...
Emergence of resistance in
Emergence of resistance in
by emma
HIV-1 Integrase . following dolutegravir (DTG) tre...
The Fast and The Continuous:
The Fast and The Continuous:
by bery
Dolutegravir-based Antiretroviral Therapy Achieves...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
Challenging Cases in Antiretroviral Therapy and Panel Discussion
Challenging Cases in Antiretroviral Therapy and Panel Discussion
by gagnon
Paul E. Sax, MD. Professor of Medicine. Harvard Me...
Dolutegravir-Lamivudine (
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Neuropsychiatric manifestations and
Neuropsychiatric manifestations and
by Mindbender
sleep disturbances in children and adolescents ran...
Country Experience in  Monitoring New
Country Experience in Monitoring New
by fauna
ARVs: Focus on Toxicity Monitoring . and Surveill...